Mindset Further Expands Portfolio of Psychedelic Drug Candidates with Third U.S. Provisional Patent Application; 50 Total New Psychedelic Patent-Pending Compounds Synthesized
Toronto, Ontario–(Newsfile Corp. – December 29, 2020) – Mindset Pharma Inc. (CSE: MSET) (“Mindset” or the “Company“), a drug discovery and development company focused on developing next generation psychedelic medicines and related technologies for the treatment of neuropsychiatric and neurological indications with unmet needs, is pleased to announce that it has filed another provisional patent […]
